Title: Jacob Gunn Glanville: Innovator in Antibody Technology
Introduction
Jacob Gunn Glanville is a notable inventor based in the United States. He has made significant contributions to the field of biotechnology, particularly in the development of methods for humanizing antibodies derived from rabbits. His innovative approach has the potential to enhance therapeutic applications in medicine.
Latest Patents
Jacob Gunn Glanville holds a patent titled "Method For Mass Humanization Of Rabbit Antibodies." This invention relates to a method for producing a population of 20 or more nucleic acids, each encoding at least one protein comprising at least one immunoglobulin variable domain. These domains have a rabbit-derived CDR3 amino acid sequence embedded in essentially human framework sequences. The patent also encompasses a population of nucleic acids and proteins related to this method, along with their uses.
Career Highlights
Throughout his career, Jacob has worked with prominent companies in the biotechnology sector. He has been associated with Abcheck S.r.o. and Charles River Laboratories, Inc. His work in these organizations has contributed to advancements in antibody technology and therapeutic development.
Collaborations
Jacob has collaborated with several professionals in his field, including Vera Molkenthin and Remko Albert Griep. These collaborations have fostered innovation and the sharing of knowledge in the biotechnology community.
Conclusion
Jacob Gunn Glanville is a pioneering inventor whose work in antibody technology has the potential to revolutionize therapeutic applications. His contributions to the field are noteworthy, and his innovative methods continue to inspire advancements in biotechnology.